It helps diagnose bleeding disorders, monitor anticoagulant therapy, and identify clotting abnormalities, guiding doctors in selecting appropriate treatment strategies for patients with suspected coagulation issues.

No, it specifically evaluates fibrinogen function and thrombin activity. Other clotting tests may be required for a complete assessment of coagulation disorders.

It helps detect fibrinogen abnormalities, monitor anticoagulant therapy, and identify inhibitors affecting clot formation, supporting diagnosis of bleeding disorders or clotting abnormalities.

Certainly, anticoagulants like heparin or direct thrombin inhibitors can prolong thrombin time. Patients should inform their doctor about medications before undergoing the test.